WELCOME TO THE MANUFACTURING REPORT
Newsletter | Member Login | Signup
Home > Companies > Optomec
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Conference
Additive Manufacturing
Optomec | May 18, 2022
Optomec, a profitable high-growth pioneer in production Additive Manufacturing, announced another important milestone in its continued growth, with the delivery of its 600th industrial 3D printer. The company has now installed more than 250 of its proprietary LENS™ Systems for 3D Printed Metal and over 350 of its patented Aerosol Jet® Systems, with the majority of its recent machines being used for high ROI production applications. Optomec has long been at the forefront ...
Optomec | March 04, 2019
Metal 3D printing systems manufacturer, Optomec, has launched two new controlled atmosphere direct energy deposition (DED) systems based on its LENS (Laser Engineered Net Shaping) technology series. The new configurable LENS CS 600 and CS 800 Controlled Atmosphere (CA) DED Systems are designed to maximize the LENS process build envelope within a small machine footprint while CA chambers allow for processing of both non-reactive and reactive metals in an atmosphere that keeps moisture and ...
Keppel Offshore & Marine, Lloyd's Register | January 14, 2020
Keppel Offshore & Marine has received Lloyd’s Register LR Certification to additively manufacture offshore grade steel with a 3D printing technology from Singapore Institute of Manufacturing Technology SIMTech. The certification was granted after assessing Keppel O&M’s production processes, from design to post-processing and testing. Partnering with Nanyang Technological University, Singapore NTU Singapore and SIMTech’s Agency for Science, Technology and Research A*STAR...
Outsourcing-Pharma.com | January 13, 2020
BMS and Catalent disclosed the deal for the site in June, at which time they hoped to work through the regulatory approvals and union consultations needed to close the transaction by the end of the year. One week into 2020, Bristol-Myers revealed it had closed the deal. The deal covers a 19,300-square-meter manufacturing facility in Anagni, a town in central Italy, that lists cardiovascular, neuroleptics, anticancer, metabolic and anti-inflammatory medicines among the drugs it makes and packages...
Article
Industrial 4.0
Manufacturing Technology
Whitepaper
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Welcome back!
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE